Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
2014 1
2015 1
2019 3
2020 5
2021 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial.
Elena CM, Fulvia PF, Emanuela R, Luigi C, Alessandra B, Rosaria VM, Antonella F, Fable Z, Gabriella M, Davide T, Nicoletta C, Stefania G, Serena C. Elena CM, et al. Among authors: nicoletta c. Clin Breast Cancer. 2025 Aug;25(6):560-565.e2. doi: 10.1016/j.clbc.2025.05.003. Epub 2025 May 13. Clin Breast Cancer. 2025. PMID: 40500613 Clinical Trial.
13 results